TS-VV GmbH
↗Baesweiler, Germany
TS-VV GmbH is the private investment and asset management firm of Thomas Schmitz, a prominent figure in the German biotechnology sector. The company serves as a family office and venture holding vehicle, primarily focusing on strategic investments in life sciences, medical technology, and innovative tech startups.
Leveraging the founder's deep expertise from scaling PAION AG, TS-VV provides not only capital but also strategic advisory to its portfolio companies. The firm is active in the Aachen/Baesweiler biotech cluster, one of Germany's leading hubs for medical innovation, and often participates in early-stage and growth financing rounds for high-tech ventures.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Investment Management
Sub-Industry:Biotech & Life Sciences Venture Capital
SIZE & FINANCIALS
Employees:1-50
Revenue:Private Investment Holding
Founded:2004
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Investment Vehicle
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Medical Devices, Digital Health
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:PAION AG (Historical/Shareholder), Hemovent GmbH (Previous investment), Gremse-IT (Portfolio company)
COMPETITION
Position:Niche Player
Competitors:Forbion, LBBW Venture Capital, High-Tech Gründerfonds (HTGF)
LEADERSHIP
Key Executives:
Thomas Schmitz - Managing Director
LINKS
Website:ts-vv.de
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TS-VV GmbH. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.